Blood-based T‑cell receptor sequencing reveals immune “fingerprints” in Lynch syndrome, helping track precancers early and paving the way for new cancer surveillance biomarkers.
Eduardo Vilar-Sanchez, MD, PhD
Advertisement
Eduardo Vilar-Sanchez, MD, PhD, is a Professor (Term Tenure), Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.
Articles by Eduardo Vilar-Sanchez, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
How Turning to Psychedelics Can Help Patients With Cancer Heal
2
"You're Home": Why Young Women With Lung Cancer Are Being Missed
3
Do Clinical Trial Results Hold Up in the Real World? A New Study on ALK+ Lung Cancer Says Yes—Mostly
4
ASCO 2026 Breast Cancer Trials Affirm De-Escalation, Earlier Switching
5